Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial DNA and RNA refer to the nucleic acid polymers (deoxyribonucleic acid for DNA, ribonucleic acid for RNA) present in microbes such as bacteria, viruses, and fungi. DNA holds the genetic blueprint and is essential for inheritance, coding for proteins, and cellular instructions, while RNA acts as the messenger and functional intermediary, directing protein synthesis and regulating gene expression[6][7][1][3]. In medicine, microbial DNA and RNA are detected for diagnosis of infections and sometimes targeted by antimicrobials or immune therapies. However, these are not molecular targets in the usual sense (such as a defined protein receptor or enzyme), but represent broad classes of molecules recognized in infectious disease contexts.
Inhibition of nucleic acid synthesis (by drugs targeting polymerases or other replication machinery) Immune recognition (pattern-recognition receptors detect microbial DNA/RNA) Direct degradation (e.g., RNases)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acid of microbial origin (DNA or RNA).